Literature DB >> 14265

Role of bacterial microflora in development of intestinal lesions from graft-versus-host reaction.

D W van Bekkum, S Knaan.   

Abstract

Acute secondary disease was induced in (C57BL X CBA)F1 mice by transplanting CBA bone marrow and spleen cells following lethal whole-body irradiation. The lesions of graft-versus-host (GvH) disease were scored quantitatively by counting of degenerated crypts in subcutaneous fetal gut implants that were free of bacteria. In conventional F1 mice the damage in F1 fetal gut was twice as great as in F1 fetal gut implants carried by decontaminated chimeras. CBA fetal gut implants developed substantial damage when present in conventional chimeras, but not when present in decontaminated chimeras. These results could be explained by assuming the presence of cross-reacting antigens on intestinal bacteria and in the gut epithelial tissue. They also explained the profound protection against delayed GvH mortality provided by removal of the intestinal microflora.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 14265     DOI: 10.1093/jnci/58.3.787

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  39 in total

Review 1.  Graft-versus-host disease of the intestine.

Authors:  G J Cox; G B McDonald
Journal:  Springer Semin Immunopathol       Date:  1990

2.  Cytokine levels following allogeneic hematopoietic cell transplantation: a match-pair analysis of home care versus hospital care.

Authors:  Olle Ringdén; Mats Remberger; Johan Törlén; Sigrun Finnbogadottir; Britt-Marie Svahn; Behnam Sadeghi
Journal:  Int J Hematol       Date:  2021-02-05       Impact factor: 2.490

Review 3.  [Is the administration of immunoglobulins following bone marrow transplantation indicated?].

Authors:  H G Klingemann
Journal:  Klin Wochenschr       Date:  1987-09-15

4.  The influence of gut-decontamination prophylactic antibiotics on acute graft-versus-host disease and survival following allogeneic hematopoietic stem cell transplantation.

Authors:  Bertrand Routy; Caroline Letendre; David Enot; Maxime Chénard-Poirier; Vikram Mehraj; Noémie Charbonneau Séguin; Khaled Guenda; Kathia Gagnon; Paul-Louis Woerther; David Ghez; Silvy Lachance
Journal:  Oncoimmunology       Date:  2016-12-27       Impact factor: 8.110

5.  Is human cell therapy research caught in a mousetrap?

Authors:  A John Barrett; J Joseph Melenhorst
Journal:  Mol Ther       Date:  2011-02       Impact factor: 11.454

6.  Reduction of aGVHD using chicken antibodies directed against intestinal pathogens in a murine model.

Authors:  Abdellatif Bouazzaoui; Elisabeth Huber; Alexander Dan; Faisal A Al-Allaf; Jochen Pfirstinger; Günter Sprotte; Josef Köstler; Andreas Hiergeist; Andre Gessner; Wolfgang Herr; Ernst Holler
Journal:  Blood       Date:  2016-12-23       Impact factor: 22.113

Review 7.  Danger signals activating innate immunity in graft-versus-host disease.

Authors:  Robert Zeiser; Olaf Penack; Ernst Holler; Marco Idzko
Journal:  J Mol Med (Berl)       Date:  2011-05-15       Impact factor: 4.599

8.  LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation.

Authors:  K R Cooke; A Gerbitz; J M Crawford; T Teshima; G R Hill; A Tesolin; D P Rossignol; J L Ferrara
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

Review 9.  Mouse models in bone marrow transplantation and adoptive cellular therapy.

Authors:  Caroline Arber; Malcolm K Brenner; Pavan Reddy
Journal:  Semin Hematol       Date:  2013-06-11       Impact factor: 3.851

10.  The relationship between faecal endotoxin and faecal microflora of the C57BL mouse.

Authors:  M J Rogers; R Moore; J Cohen
Journal:  J Hyg (Lond)       Date:  1985-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.